These findings demonstrate that SNHG26 confers protection against cuproptosis in CRC cells, and its depletion substantially enhances the therapeutic efficacy of Cu + ELES, suggesting a previously unrecognised role for SNHG26 in modulating copper‐dependent cell death pathways. This evidence concerns the gene SNHG26 and colorectal carcinoma.